Trade Talis Biomedical Corporation - TLIS CFD
Add to favourite- Summary
- Historical Data
Spread | 0.26 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 9.04 |
Open | 9.27 |
1-Year Change | 1754% |
Day's Range | 8.77 - 9.27 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
May 8, 2024 | 8.98 | -0.29 | -3.13% | 9.27 | 9.27 | 8.72 |
May 7, 2024 | 9.04 | 0.16 | 1.80% | 8.88 | 9.37 | 8.84 |
May 6, 2024 | 9.13 | -0.03 | -0.33% | 9.16 | 9.47 | 8.62 |
May 3, 2024 | 9.12 | 0.01 | 0.11% | 9.11 | 9.27 | 8.93 |
May 2, 2024 | 8.96 | -0.01 | -0.11% | 8.97 | 9.06 | 8.82 |
May 1, 2024 | 8.62 | -0.35 | -3.90% | 8.97 | 9.05 | 8.62 |
Apr 30, 2024 | 8.59 | -0.48 | -5.29% | 9.07 | 9.17 | 8.40 |
Apr 29, 2024 | 9.04 | 0.37 | 4.27% | 8.67 | 9.15 | 8.67 |
Apr 26, 2024 | 9.11 | 0.54 | 6.30% | 8.57 | 9.11 | 8.57 |
Apr 25, 2024 | 8.57 | -0.17 | -1.95% | 8.74 | 8.97 | 8.57 |
Apr 24, 2024 | 9.07 | 0.24 | 2.72% | 8.83 | 9.17 | 8.83 |
Apr 23, 2024 | 8.97 | 0.09 | 1.01% | 8.88 | 9.13 | 8.72 |
Apr 22, 2024 | 8.97 | 0.12 | 1.36% | 8.85 | 9.05 | 8.69 |
Apr 19, 2024 | 8.87 | 0.15 | 1.72% | 8.72 | 9.08 | 8.44 |
Apr 18, 2024 | 8.67 | 0.47 | 5.73% | 8.20 | 8.87 | 8.20 |
Apr 17, 2024 | 8.42 | -0.07 | -0.82% | 8.49 | 8.62 | 8.26 |
Apr 16, 2024 | 8.29 | 0.01 | 0.12% | 8.28 | 8.44 | 8.28 |
Apr 15, 2024 | 8.28 | 0.01 | 0.12% | 8.27 | 8.33 | 8.18 |
Apr 12, 2024 | 8.17 | -0.08 | -0.97% | 8.25 | 8.49 | 8.13 |
Apr 11, 2024 | 8.42 | 0.10 | 1.20% | 8.32 | 8.42 | 7.97 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Talis Biomedical Corporation Company profile
About Talis Biomedical Corp
Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Talis Biomedical Corp revenues decreased 25% to $8.2M. Net loss increased from $91.1M to $192M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$3.88 to -$7.30.
Industry: | Biotechnology & Medical Research (NEC) |
1100 Island Drive
Suite 101
REDWOOD CITY
CALIFORNIA 94065
US
News
Bank of England preview: possible rate cut in summer?
The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.
12:39, 8 May 2024We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com